comparemela.com

Latest Breaking News On - Benaree pratt wiley - Page 1 : comparemela.com

CBIZ (NYSE:CBZ) Updates FY23 Earnings Guidance

CBIZ (NYSE:CBZ – Get Free Report) issued an update on its FY23 earnings guidance on Thursday morning. The company provided earnings per share guidance of $2.36 to $2.41 for the period, compared to the consensus earnings per share estimate of $2.33. The company issued revenue guidance of +10-12% yr/yr to ~$1.55-1.58 billion, compared to the […]

CBIZ (NYSE:CBZ) Updates FY23 Earnings Guidance

CBIZ (NYSE:CBZ – Get Free Report) updated its FY23 earnings guidance on Thursday. The company provided EPS guidance of $2.36 to $2.41 for the period, compared to the consensus EPS estimate of $2.33. The company issued revenue guidance of +10-12% yr/yr to ~$1.55-1.58 billion, compared to the consensus revenue estimate of $1.56 billion. Wall Street […]

Vanguard Personalized Indexing Management LLC Increases Holdings in CBIZ, Inc (NYSE:CBZ)

Vanguard Personalized Indexing Management LLC lifted its position in CBIZ, Inc. (NYSE:CBZ – Free Report) by 4.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,100 shares of the business services provider’s stock after purchasing an additional 308 shares during the […]

Form N-CSR BNY Mellon Alcentra Glob For: Aug 31

Form N-CSR BNY Mellon Alcentra Glob For: Aug 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

CBIZ (NYSE:CBZ) Research Coverage Started at StockNews com

StockNews.com began coverage on shares of CBIZ (NYSE:CBZ – Free Report) in a report released on Thursday. The brokerage issued a hold rating on the business services provider’s stock. Separately, Sidoti cut CBIZ from a buy rating to a neutral rating and set a $58.00 target price for the company. in a research report on […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.